US FDA Panel To Take Up Lutonix DCB Catheter For Lower-Leg Use Next Month
Executive Summary
If approved, the device will be the first drug-coated balloon indicated specifically for use in arteries below the knee.
You may also be interested in...
FDA Panel Votes No On BD's Balloon For Below The Knee
Shifting trial design and missing data, plus little evidence of benefit, worked against the paclitaxel-coated balloon, panelists and US FDA speakers said.
MedAlliance Launches PRISTINE Study Of SELUTION SLR Drug-Eluting Peripheral Balloon
SELUTION SLR is the first drug-eluting balloon accepted by the FDA as part of its breakthrough program, according to the company.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.